Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : APMP (formerly APM) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (11261)	5/22/1998 9:58:00 PM
From: AlienTech	Respond to of 13456

Oh I dont think VVUS will behave exactly like ENMD going from 10 to 80! But if there is enough publicity then I can see it going from 10 to 15 easily and then crossing over to 20 if the recent shorts get nervous. Also monday will be another script day. Another thing was that it might be harder to get approval in Europe now and with the publicity they will be ultra careful not to do the same thing as the fast track FDA. Now if everyone adds a line saying VVUS has a competing product without these side effects then I can surely see VVUS hitting 80 but thats just not the case but good for a pop never the less. And a point pop in VVUS is 10%, hey not bad.. But then again I can make the same if I was short APM.. hmmmmm.... Fair value of Vivus is over $20.00/share. The following events should help at least double our share price. 1)FDA approval of new plant--to be announced no later than Monday June first. 2)Increasing script numbers starting week ending May 15. 3)Viagra hype coming to an end. The media hyped it and now they will bash it which is typical of great American journalism. 4)Short interest still ridiculously high. Maybe the shorts will start thinking about covering when we hit 15 and they can then cover us to 20+. 5)A lot of money is leaving big name computer/chip stocks and fund managers are now looking for VALUE. Vivus is VALUE at current prices. 6)Rumors have been hot about Astra or Janssen buying out Vivus. If this is so you can expect at least a 100% gain the day the announcement is made. 7)Over the last year international sales were not a consideration in the stock price but now they should be. Vivus claims that it is shipping out all product it can make. Vivus did not expect as great of a demand as is presently occuring in England. Lower demand in the USA during the Viagra hype has actually been a blessing for Vivus--they are able to ship extra product to Astra for sale in England which would have been in short supply if more MUSE was needed domestically. England will not have a supply shortage which adversely effected MUSE sales in the USA when supply could not meet demand. To those waiting on the sidelines wondering what to do all I can say is jump in on Tuesday while the price is still low. The media exposure this Friday alone has been very good for Vivus. Vivus is getting free media exposure for MUSE as a safe local alternative to the dangers of Viagra. Just watch the news this weekend for more free MUSE press. Maybe Jay Leno will crack a few more MUSE jokes like last time which popped us to $15.00+ in a few trading days.